1-5 of 5
Mari Luz Amigo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Deubiquitnase BAP1 Downregulation in Myeloid Malignances: A New Pathogenic Mechanism, Dominant in Chronic Myelomonocytic Leukemia

Free
Ana Maria Hurtado, Eva Caparrós, Jose Miguel Torregrosa, Ginés Luengo, Mara Toderici, María Eugenia De la Morena, Begoña Muiña, Maria Luisa Lozano, Constant Martinez, Mari Luz Amigo, Felipe De Arriba, Francisco Ortuño, Raul Teruel Montoya, PhD, Francisca Ferrer-Marin, MD, PhD, Vicente Vicente, MD PhD, Andres Jerez, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5594.
https://doi.org/10.1182/blood.V124.21.5594.5594
Published: 2014
Journal Articles

Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HCT) In Patients With Relapsed Or Refractory Acute Leukemia

Free
Josefina Serrano, Diana Buenasmañanas, P Herrera, Mari Luz Amigo, Marisa Calabuig, Eusebio Martin, PhD, Maria-Belén Vidriales, Adolfo de la Fuente, M Santero, Silvia Negri, Jose Gonzalez-Campos, Carmen Albo, Sonia Gonzalez, Jose J. Rifon, MD, M Cruz Viguria, V Garcia-Gutierrez, Carmen Martin, Joaquin Sanchez-Garcia
Journal: Blood
Blood (2013) 122 (21): 3410.
https://doi.org/10.1182/blood.V122.21.3410.3410
Published: 2013
Journal Articles

A Phase I/II, National, Multicenter, Open Label Study of Bortezomib (Velcade) and Fludarabine, Cytarabine and Idarubicin (Flag-Ida) (V-Flag-Ida) in Pts with Relapsed and/or Refractory Acute Myeloblastic Leukemia (AML).

Free
Maria-Victoria Mateos, Rafael Martínez, Salut Brunet, Maria-Belén Vidriales, Albert Oriol, MD, Juan José Lahuerta, MD, PhD, Mari Luz Amigo, Jordi Esteve, Javier de la Rubia, Luis Palomera, Javier Bueno, Jesus F San Miguel
Journal: Blood
Blood (2009) 114 (22): 4140.
https://doi.org/10.1182/blood.V114.22.4140.4140
Published: 2009
Journal Articles

Independent Impact of Iron Overload and Transfusion Dependency on Survival and Leukemic Evolution in Patients with Myelodysplastic Syndrome

Free
Guillermo Sanz, MD, PhD, Benet Nomdedeu, MD, Esperanza Such, Teresa Bernal, MD, Mohamed Belkaid, Ma Teresa Ardanaz, MD, Victor Marco, MD, Carme Pedro, MD, Fernando Ramos, MD, PhD, MPH, Maria Consuelo del Cañizo, MD, PhD, Elisa Luño, MD, Francesc Cobo, MD, Felix Carbonell, MD, Valle Gomez, MD, Juan A Muñoz, MD, Mari Luz Amigo, MD, Alicia Bailen, MD, Santiago Bonanad, MD, Mar Tormo, MD, Rafael Andreu, Beatriz Arrizabalaga, MD, Maria J. Arilla, MD, Javier Bueno, MD, Maria J. Requena, MD, Joan Bargay, MD, Joaquin Sanchez, MD, Leonor Senent, MD, Leonor Arenillas, MD, Raquel de Paz, MD, PhD, Blanca Xicoy, MD, Rafael Duarte, MD, PhD, Jose Cervera, MD
Journal: Blood
Blood (2008) 112 (11): 640.
https://doi.org/10.1182/blood.V112.11.640.640
Published: 2008
Journal Articles

ERG, EVI1 and PRAME Are Relevant Markers of Treatment Response and Survival, and They Could Be Useful for Improving the Risk-Stratification in Citogenetically Normal Acute Myeloid Leukemia (CN-AML)

Free
Carlos Santamaría, Carmen Chillón, Ramon García-Sanz, Cristina Pérez, Fernando Ramos, Alfonso García de Coca, Jose- Maria Alonso, Pilar Giraldo, Teresa Bernal, José-Antonio Queizán, José Nicolas Rodríguez, Pascual Fernández-Abellán, Abelardo Barez, María-José Peñarrubia, Mari Luz Amigo, Alejandro Martín García-Sancho, Miguel Angel Pozas, Ana Balanzategui, Joaquin Díaz-Mediavilla, Jesús F. San Miguel, Marcos González
Journal: Blood
Blood (2008) 112 (11): 4844.
https://doi.org/10.1182/blood.V112.11.4844.4844
Published: 2008